3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Carcinoma, Hepatocellular
9
Neoplasms
4
Melanoma
4
Breast Neoplasms
4
Lymphoma, B-Cell, Marginal Zone
3
Lymphoma
3
Sarcoma
2
Prostatic Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Polycystic Ovary Syndrome
2
Pleural Effusion, Malignant
2
Neoplasm Metastasis
2
Mesothelioma, Malignant
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Head and Neck Neoplasms
2
Anxiety Disorders
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Recurrence
1
Rare Malignant Neoplasm
1
Pancreatic Neoplasms
1
Neuroblastoma
1
Neoplasms, Plasma Cell
1
NSCLC
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Lymphedema
1
Locally Advanced Bladder Cancer
1
Immunoglobulin Light-chain Amyloidosis
1
Interventions
Cyclophosphamide
81
fludarabine phosphate
77
Peripheral Blood Stem Cell Transplantation
62
Mycophenolic Acid
55
Tacrolimus
54
Whole-Body Irradiation
52
Busulfan
51
Antilymphocyte Serum
45
Cyclosporine
41
fludarabine
36
Methotrexate
32
Filgrastim
32
Melphalan
30
Radiotherapy
25
Methylprednisolone
19
Cytarabine
17
Cord Blood Stem Cell Transplantation
17
Sirolimus
15
Azacitidine
15
Granulocyte Colony-Stimulating Factor
14
Alemtuzumab
14
thymoglobulin
13
Flow Cytometry
13
Etoposide
13
Cyclosporins
13
Specimen Handling
10
Biopsy
10
Thiotepa
9
Psychiatric Rehabilitation
9
Decitabine
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Myeloproliferative Disorders
×
Pharmaceutical Preparations
×
Clear all
NCT04994158
2025-07-30
MASCOT-R
Royal Free Hospital NHS Foundation Trust
Completed
238 enrolled